Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.

Abstract

In 2016, the World Health Organisation set a goal to eliminate viral hepatitis by 2030. Robust epidemiological information underpins all efforts to achieve elimination and this systematic review provides estimates of HBsAg and anti-HCV prevalence in the European Union/European Economic Area (EU/EEA) among three at-risk populations: people in prison, men who have sex with men (MSM), and people who inject drugs (PWID)

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the following location(s):}

http://www.openarchives.org/OA... (external link)

http://rivm.openrepository.com... (external link)

http://hdl.handle.net/10029/62... (external link)